Enterprise Therapeutics taps Morris as chief medical officer

Enterprise Therapeutics Ltd, a biopharmaceutical company focused on treating patients with respiratory disease, has named Dr. David Morris as chief medical officer.

ByIris Dorbian

10 February 2020•2 mins read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.

Healthcare Human Resources Briefs

Enterprise Therapeutics taps Morris as chief medical officer

Novartis Venture Fund